Hey Snackers,
When cat food meets high-end Italian dining: Pet food maker Fancy Feast is launching an upscale pop-up restaurant in NYC so you and your feline can enjoy pawsta together.
Stocks gained again yesterday despite news that the US economy shrank for a second-straight quarter — more evidence that the US could be in a recession. After market close, Amazon stock surged on rosier-than-expected sales (despite another quarterly loss). Apple stock popped after it reported record third-quarter revenue despite slowing growth.
Build Back Better is back… Well, almost. Yesterday Democratic Senator Joe Manchin struck a surprise deal with Dems to support a climate and tax bill, reopening the door for some — but not all — of Biden’s agenda. Manchin initially opposed Biden’s “Build Back Better” plan on fears it would spike #flation, but says the new bill will do the opposite:
Renewed hope for renewables… In recent months, renewable companies’ earnings have been clouded by rising prices: the cost of key solar materials has nearly tripled from last January. But solar demand’s still strong, and this bill could boost green investment:
It’s a historic step for climate investment… But still just the beginning. Experts say the new climate bill could pass as early as next week, if it gets the support from all 50 Democratic Senators (wild-cards like Kyrsten Sinema could kill the deal). It’ll still take years for America to overhaul its old energy infrastructure, but certain companies and consumers may benefit right away.
Shoot your (multi-billion dollar) shot... Pfizer's sales hit a record high last quarter, surging 27% from last year to nearly $28B. More than half of that revenue came from Covid shots or Covid treatments. Meanwhile, total profit ballooned 78% to nearly $10B.
Halloween and vaccines... If it seems like everyone’s getting Covid, that’s because the dominant BA.5 Omicron subvariant is more transmissible than past ones. As Covid resurges, the FDA has asked vaccine-makers to target dominant subvariants for a wave of fall boosters. Last month, Pfizer and its vax partner BioNTech struck a $3.2B deal with the US gov't to deliver 105M doses ahead of an increasingly-likely fall vaccination campaign.
Out of mind ≠ out of sight… The pandemic used to dominate every headline and conversation. It isn’t monopolizing our daily lives like it was two years ago — from loosening restrictions to lessening news coverage. Still, the US is dealing with 130K new daily Covid cases and a rising death toll. For reference: daily cases are at the same high level that they were in November 2020. Now, health officials worry that the US will face an even bigger wave when summer ends — and vax-makers will be key to tackling it.
Authors of this Snacks own: shares of Apple, Exxon, Shell, Amazon, Comcast, and Spirit
ID: 2319407